Abcore’s caring animal husbandry process ensures the development of healthy animals which provide high quality, untarnished, antibodies. Southern California’s mild year round climate allows the animals to be housed in open air facilities; in a stress free environment; under constant observation from experienced certified animal technicians and fed on a specially developed diet.
With the opening of the San Diego Office, Abcore’s US clients can benefit from quick delivery of products they know have been produced to the highest possible standards within nationally recognized guidelines and monitoring processes and they can speak directly to the local office. Importation of serums to Europe will be handled by Abcore’s UK office, which will also cover transatlantic transport costs.
Abcore’s San Diego office will provide marketing, distribution, technical and market development services easing the ability for European biotech companies to trade across North America under their own brand. By using Abcore’s services, companies can substantially reduce much of the cost and time that biotech companies usually have to undergo, to trade across the world’s biggest Life Science market.
Tim Bernard, director, Abcore, said, “Healthy animals provide healthy antibodies, and the environment and scientific practice at our San Diego facility ensures Abcore’s products are some of the best available and of a guaranteed high standard. Our new office also provides European biotech companies with the chance to establish a base in the USA, without any of the usual obstacles, from which they can grow under their own identity.”
For further information contact:
Tim Bernard, Abcore: email: tim@abcore-inc.com tel: 00 44 (0)1869 238377
Abcore (Abcore-inc.com) is a new company that has been set up by Tim Bernard, director of biotechnology consultancy, Pivotal Scientific (pivotalscientific.com) based in Oxford, UK and Steven Evans. Abcore will produce Polyclonal antibodies produced at USDA and NIH registered facilities in the USA. Abcore will offer:
- Short development protocols with first production serum available in 35 days
- Guarantee of antibody titer of 15000:1 to immunogen
- Free peptide design
- Peptide synthesis
- All transport costs within the UK
- Importation of serums handled by local UK office
- All monetary transactions in local currency
- Customer service directly with US facility
